Gradually , focus is growing within the United Kingdom regarding the drug as a promising treatment for lipodystrophy . While somewhat emerging , knowledge of its potential benefits – particularly in addressing the symptoms of HIV-related lipodystrophy – is spreading . Doctors are investigating its suitability, and interest from individuals is